Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 28.03M | 29.34M | 13.35M | 10.87%75.73M | 42.43%68.3M | 4.73%47.95M | 3.42%45.79M | 6.22%44.27M | -31.98%41.68M | 27.08%61.28M |
| Cost of revenue | 18.68M | 19.86M | 9.39M | 7.02%54.76M | 36.74%51.16M | 10.09%37.42M | 4.55%33.99M | -10.78%32.51M | -28.47%36.43M | 39.15%50.93M |
| Gross profit | 9.34M | 9.47M | 3.96M | 22.37%20.97M | 62.66%17.14M | -10.70%10.54M | 0.27%11.8M | 124.28%11.77M | -49.29%5.25M | -10.97%10.34M |
| Operating expense | 2.83M | 2.86M | 1.85M | 26.80%7.08M | 10.53%5.58M | 7.35%5.05M | -23.30%4.7M | -30.54%6.13M | 17.26%8.83M | 45.22%7.53M |
| Selling and administrative expenses | --2.83M | --2.86M | --1.85M | 26.80%7.08M | 11.30%5.58M | 24.75%5.01M | -16.89%4.02M | -24.28%4.84M | -15.16%6.39M | 170.31%7.53M |
| -Selling and marketing expense | --636K | --777K | --576K | -6.67%2.12M | 3.12%2.27M | 27.09%2.2M | -3.70%1.73M | -15.31%1.8M | 5.79%2.13M | 0.20%2.01M |
| -General and administrative expense | --2.19M | --2.09M | --1.28M | 49.81%4.95M | 17.73%3.31M | 22.97%2.81M | -24.73%2.28M | -28.76%3.03M | -22.80%4.26M | 609.15%5.52M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | -88.70%77.28K | -47.20%684.06K | -46.93%1.3M | --2.44M | ---- |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | --42.16K | ---- | --0 | ---- | ---- |
| Operating profit | 6.51M | 6.61M | 2.11M | 20.23%13.89M | 110.63%11.56M | -22.67%5.49M | 25.91%7.1M | 257.34%5.64M | -227.15%-3.58M | -56.23%2.82M |
| Net non-operating interest income (expenses) | -503K | -374K | -269K | -1.06%-1.06M | -13.05%-1.05M | -80.88%-926K | 46.05%-511.95K | 19.66%-948.87K | 8.60%-1.18M | -69.70%-1.29M |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | -10.01%25.92K | -72.94%28.81K | 2,088.08%106.45K | --4.87K | ---- |
| Non-operating interest expense | --503K | --374K | --269K | 1.06%1.06M | 13.76%1.05M | 97.22%920.21K | -55.41%466.6K | -8.32%1.05M | -6.47%1.14M | 56.27%1.22M |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | -57.23%31.72K | 731.20%74.15K | -80.01%8.92K | -37.98%44.63K | 181.10%71.96K |
| Net investment income | 143.55%95.91K | 296.24%39.38K | -76.79%9.94K | 42.82K | ||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -39.96%679.43K | -79.51%1.13M | 209.62%5.52M | 1.78M | ||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | -156.98%-110.5K | 98.98%-43K | ---4.21M | ---- | ---- |
| Less:Write off | ---- | ---- | ---- | ---- | ---- | 47.74%-568.93K | 16.85%-1.09M | 26.59%-1.31M | ---1.78M | ---- |
| Other non-operating income (expenses) | 77K | 37K | 13K | -17.42%594.98K | 640.25%720.49K | 3.26%97.33K | 685.49%94.26K | 12K | 16,526.86%2.96M | |
| Income before tax | 6.09M | 6.27M | 1.86M | 19.60%13.43M | 106.69%11.23M | -30.77%5.43M | -23.28%7.85M | 448.44%10.23M | -165.52%-2.94M | -36.03%4.48M |
| Income tax | 1.45M | 1.79M | 581K | 26.20%3.46M | 44.44%2.74M | -9.48%1.9M | 0.40%2.1M | 1,424.81%2.09M | -91.52%136.86K | 90.43%1.61M |
| Net income | 4.63M | 4.49M | 1.28M | 17.47%9.97M | 140.07%8.49M | -38.53%3.54M | -29.35%5.75M | 365.01%8.14M | -207.18%-3.07M | -53.43%2.87M |
| Net income continuous operations | --4.63M | --4.49M | --1.28M | 17.47%9.97M | 140.07%8.49M | -38.53%3.54M | -29.35%5.75M | 365.01%8.14M | -207.18%-3.07M | -53.43%2.87M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 4.63M | 4.49M | 1.28M | 17.47%9.97M | 140.07%8.49M | -38.53%3.54M | -29.35%5.75M | 365.01%8.14M | -207.18%-3.07M | -53.43%2.87M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 4.63M | 4.49M | 1.28M | 17.47%9.97M | 140.07%8.49M | -38.53%3.54M | -29.35%5.75M | 365.01%8.14M | -207.18%-3.07M | -53.43%2.87M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 0.0205 | 0.0199 | 0.0059 | 17.56%0.0462 | 139.63%0.0393 | -38.35%0.0164 | -29.44%0.0266 | 294.33%0.0377 | -246.15%-0.0194 | -53.42%0.0133 |
| Diluted earnings per share | 0.0205 | 0.0199 | 0.0051 | 17.56%0.0462 | 139.63%0.0393 | -38.35%0.0164 | -29.44%0.0266 | 294.33%0.0377 | -246.15%-0.0194 | -53.42%0.0133 |
| Dividend per share | 0 | 0 | 0 | 0.00%0.01 | -28.57%0.01 | -39.13%0.014 | 64.29%0.023 | 0.014 | ||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.